Atlas Trials

Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus

RecordFirmDate
To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients (NCT04468646)Prof. Dr. Fridoon Jawad Ahmad2020-06-15

Track Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus automatically

Every clearance here is in the API, with alerts when new ones post.